MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16.
Ann Rheum Dis
; 74(6): 1156-63, 2015 Jun.
Article
in En
| MEDLINE
| ID: mdl-25512675
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Osteitis
/
Polyethylene Glycols
/
Arthritis, Rheumatoid
/
Synovitis
/
Immunoglobulin Fab Fragments
/
Hand Joints
/
Antibodies, Monoclonal, Humanized
/
Immunosuppressive Agents
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2015
Type:
Article